We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Low Radiation Doses in Nature May Pose Risk

By Biotechdaily staff writers
Posted on 20 May 2002
A study has found that radiation can trigger widespread mutations in living cells at much lower doses than previously thought possible. More...
Conducted by researchers at Columbia University College of Physicians and Surgeons (New York, NY, USA), the study was published in the December 4, 2001, issue of the Proceedings of the National Academy of Sciences.

The study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic effect as a dose that strikes every cell. The added damage occurs because of what is called the "bystander effect,” in which injured cells send aberrant signals to neighboring cells. This effect occurs with alpha particles, which come from such sources as nuclear explosions, plutonium, and radon, a naturally occurring gas that seeps into many homes.

The risks of exposure to lower radiation levels are poorly understood and have been the subject of controversy for decades, say the researchers. In the study, they found that when they beamed alpha particles at only one in 10 cells, the results were almost the same as if they had beamed them at all cells. Nearly all the cells showed mutations in their DNA. However, the researchers found they could prevent widespread damage by blocking the signaling network that exists between cells. By using chemicals that obstruct key cell-to-cell pathways, the researchers could restrict the damage to the 10% of cells that had directly received alpha particles. This suggests that signaling networks are responsible for spreading the damage, but little is known about the signaling mechanism at this time.

Previously, public health officials have assumed the risk of radiation is proportional to the dose. Lower doses carry lower risk. The new findings suggest such a linear relationship might not be operating. Instead, the study suggests that at low doses, the risk rises steeply in proportion to the dose, while at higher doses, the risk rises more gently in relation to the dose.

According to Dr. Howard L. Liber, associate professor of radiobiology at Harvard School of Public Health, the study is "another piece of hard evidence to suggest we may need to reassess acceptable radiation levels.”


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.